Cargando…

RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection

Detalles Bibliográficos
Autores principales:	Huang, Jiaming, Lin, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Society of Gastroenterology 2023
Materias:	Author’s Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210858/ https://www.ncbi.nlm.nih.gov/pubmed/37089053 http://dx.doi.org/10.5152/tjg.2023.231302

Ejemplares similares

Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Düzenli, Tolga, et al.
Publicado: (2023)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
por: Sugimoto, Mitsushige, et al.
Publicado: (2019)

Vonoprazan-Associated Gastric Mucosal Redness in Non-Helicobacter pylori-Infected and Helicobacter pylori-Eradicated Stomach
por: Kubo, Kimitoshi, et al.
Publicado: (2021)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
por: Zhang, Zinan, et al.
Publicado: (2023)

Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication
por: Kusunoki, Maho, et al.
Publicado: (2019)

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
por: Yamada, Shinya, et al.
Publicado: (2016)

The efficacy and safety of vonoprazan–amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis
por: Feng, Jia-Hui, et al.
Publicado: (2023)

Reply to the Comments from Readers
por: Wang, Min, et al.
Publicado: (2018)

Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
por: Zhang, Wen-Lin, et al.
Publicado: (2023)

A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori
por: Yang, Faming, et al.
Publicado: (2023)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Reply from Authors to the Editorial Comment
por: Kiss, Bernhard, et al.
Publicado: (2016)

Reply to Kocsmár, É.; Lotz, G. Comment on “Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133”
por: Daugule, Ilva, et al.
Publicado: (2023)

The efficacy of vonoprazan combined with different dose amoxicillin on eradication of Helicobacter pylori: an open, multicenter, randomized clinical study
por: Lin, Yimin, et al.
Publicado: (2022)

Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of H. pylori
por: Furuta, Takahisa, et al.
Publicado: (2023)

Reply to “Comments on Fouchier’s Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory”
por: Fouchier, Ron A. M.
Publicado: (2015)

Re: Commentary on “A modified fixation technique for the cure of buried penis in children”
por: Cui, Xu, et al.
Publicado: (2022)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection
por: Yu, Jing, et al.
Publicado: (2023)

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study
por: Gunaratne, Anoja W, et al.
Publicado: (2021)

Re: Is number of chiasmata an etiological factor of male infertility?
por: Sarrate, Zaida, et al.
Publicado: (2014)

Re: COVID-19 and Diagnosing Brain Death: An Ambiguity
por: Yakar, Mehmet Nuri, et al.
Publicado: (2020)

Comments on Ricardo F Savaris' Letter to the Editor regarding the publication in the JBSTM-Brazilian Protocol for Sexually Transmitted Infections, 2020: “Pelvic Inflammatory Disease”
por: Menezes, Maria Luiza Bezerra, et al.
Publicado: (2021)

RE: Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Duman, Dildar, et al.
Publicado: (2023)

Reply to the Comment Re: Magalhães-Sant’Ana, M. Animals 2019, 9, 168
por: Magalhães-Sant’Ana, Manuel
Publicado: (2020)

Response to comment on the article, “Yoga protocol for treatment of breast cancer-related lymphedema”
por: Narahari, SR, et al.
Publicado: (2017)

Response to Comment on “Effect of Glycemic Index and Glycemic Load on Atherosclerotic Stenosis and Stroke”
por: Peng, Min, et al.
Publicado: (2020)

RE: How Are Thermoregulation and Ventilatory Modes Linked? Some Methodological Views
por: Yüksek, Ahmet, et al.
Publicado: (2020)

Reply to comment on: “Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors”
por: Shukla, Palak, et al.
Publicado: (2018)

Comments on the Measurement of Lung Cancer Tumor Markers in Workers of a Glass Wool Company
por: Abtahi, Shabnam, et al.
Publicado: (2018)

Re: Clinical Trials in Volume Resuscitation with Hydroxyethyl Starch: Focus on Risk of Bias
por: Ünal, M. Necmettin, et al.
Publicado: (2020)

Comments regarding use of rifabutin for Helicobacter pylori eradication
por: Graham, David Y.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ojh9kjarpi2oub8q8j5b1akc8s